Evidence map›Paper›PMID 30063733›Full record

ArticlePloS one2018

Cross-sectional validation of the PROMIS-Preference scoring system.

Janel Hanmer, Barry Dewitt, Lan Yu, Joel Tsevat, Mark Roberts, Dennis Revicki, Paul A Pilkonis, Rachel Hess, Ron D Hays, Baruch Fischhoff and 3 more

Erratum issued Registry-linked trialAbstract readValidation Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06086301 (Pilot Testing Post-Intensive Care Transitions Using Rehabilitation and Engagement To Heal ICU Survivors and Families), which is not on this map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06086301 nacompletednot on this mapstarted 2023, after this paper: background citation

Pilot Testing Post-Intensive Care Transitions Using Rehabilitation and Engagement To Heal ICU Survivors and Families (PICTURE-THIS)

TypeinterventionalSponsorUniversity of PittsburghRan2023 to 2025Enrolled42ConditionsPost-intensive Care Syndrome, Transitional Care, Critical Care, Health ServicesArmsPICTURE-THIS, Enhanced Usual Care, Run-In Phase
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Gait as a quantitative indicator of the severity of chemotherapy-induced peripheral neuropathy: a pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  8. Article
  9. Article
  10. Mapping and Linking between the EQ-5D-5L and the PROMIS Domains in the United States.Medical decision making : an international journal of the Society for Medical Decision Making · 2025
    Article
  11. The Role of Patient-Reported Outcomes in Cirrhosis.The American journal of gastroenterology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Agreement of PROMIS Preference (PROPr) scores generated from the PROMIS-29 + 2 and the PROMIS-16.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Janel HanmerDepartment of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0001-6159-2482
Barry DewittDepartment of Engineering and Public Policy and Institute for Politics and Strategy, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
Lan YuDepartment of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Joel TsevatDepartment of Medicine, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas and Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, Texas, United States of America.
Mark RobertsDepartment of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Dennis RevickiOutcomes Research, Evidera, Bethesda, Maryland, United States of America.
Paul A PilkonisDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Rachel HessDivision of Health System Innovation and Research, University of Utah Schools of the Health Sciences, Salt Lake City, Utah, United States of America.
Ron D HaysDivision of General Internal Medicine & Health Services Research, UCLA, Los Angeles, California, United States of America.
Baruch FischhoffDepartment of Engineering and Public Policy and Institute for Politics and Strategy, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
David FeenyDepartment of Economics, McMaster University, Hamilton, Ontario, Canada.
David CondonDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
David CellaDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Institutional Career Development CoreKL2TR001856 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAY, KRISTIN N, RUBIO, DORIS M · 2016 to 2025
$13.8M
The National Person-Centered Assessment Resource (PCAR)U2CCA186878 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GERSHON, RICHARD · 2014 to 2018
$11.9M
PROMIS Statistical CenterU54AR057951 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CELLA, DAVID · 2009 to 2014
$3.6M
NCATS NIH HHS KL2 TR001856NCATS NIH HHS UL1 TR000005NCI NIH HHS U2C CA186878NIAMS NIH HHS U54 AR057951
6 · The paper itself

Abstract

objectivesThe PROMIS-Preference (PROPr) score is a recently developed summary score for the Patient-Reported Outcomes Measurement Information System (PROMIS). PROPr is a preference-based scoring system for seven PROMIS domains created using multiplicative multi-attribute utility theory. It serves as a generic, societal, preference-based summary scoring system of health-related quality of life. This manuscript evaluates construct validity of PROPr in two large samples from the US general population.

methodsWe utilized 2 online panel surveys, the PROPr Estimation Survey and the Profiles-Health Utilities Index (HUI) Survey. Both included the PROPr measure, patient demographic information, self-reported chronic conditions, and other preference-based summary scores: the EuroQol-5D (EQ-5D-5L) and HUI in the PROPr Estimation Survey and the HUI in the Profiles-HUI Survey. The HUI was scored as both the Mark 2 and the Mark 3. Known-groups validity was evaluated using age- and gender-stratified mean scores and health condition impact estimates. Condition impact estimates were created using ordinary least squares regression in which a summary score was regressed on age, gender, and a single health condition. The coefficient for the health condition is the estimated effect on the preference score of having a condition vs. not having it. Convergent validity was evaluated using Pearson correlations between PROPr and other summary scores.

resultsThe sample consisted of 983 respondents from the PROPr Estimation Survey and 3,000 from the Profiles-HUI survey. Age- and gender-stratified mean PROPr scores were lower than EQ-5D and HUI scores, with fewer subjects having scores corresponding to perfect health on the PROPr. In the PROPr Estimation survey, all 11 condition impact estimates were statistically significant using PROPr, 8 were statistically significant by the EQ-5D, 7 were statistically significant by HUI Mark 2, and 9 were statistically significant by HUI Mark 3. In the Profiles-HUI survey, all 21 condition impact estimates were statistically significant using summary scores from all three scoring systems. In these samples, the correlations between PROPr and the other summary measures ranged from 0.67 to 0.70.

conclusionsThese results provide evidence of construct validity for PROPr using samples from the US general population.

Indexed as

Patient Reported Outcome MeasuresAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedQuality of LifeUnited StatesYoung Adult

Identifiers

PMID30063733
PMCPMC6067708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.